Samrat Pharmachem [SAMRATPH] vs Tata Chemicals [TATACHEM] Detailed Stock Comparison

Samrat Pharmachem

BSE
Loading...

Tata Chemicals

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Samrat Pharmachem wins in 12 metrics, Tata Chemicals wins in 7 metrics, with 0 ties. Samrat Pharmachem appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSamrat PharmachemTata ChemicalsBetter
P/E Ratio (TTM)20.0075.13Samrat Pharmachem
Price-to-Book Ratio1.341.11Tata Chemicals
Debt-to-Equity Ratio13.8131.43Samrat Pharmachem
PEG Ratio-0.181.11Samrat Pharmachem
EV/EBITDA13.6115.56Samrat Pharmachem
Profit Margin (TTM)1.72%2.27%Tata Chemicals
Operating Margin (TTM)-0.06%9.92%Tata Chemicals
EBITDA Margin (TTM)N/A9.92%N/A
Return on Equity9.91%2.17%Samrat Pharmachem
Return on Assets (TTM)5.85%0.62%Samrat Pharmachem
Free Cash Flow (TTM)$-105.99M$-2.44BSamrat Pharmachem
Dividend Yield0.29%1.19%Tata Chemicals
1-Year Return-44.72%-21.67%Tata Chemicals
Price-to-Sales Ratio (TTM)0.341.61Samrat Pharmachem
Enterprise Value$1.06B$301.60BTata Chemicals
EV/Revenue Ratio0.382.04Samrat Pharmachem
Gross Profit Margin (TTM)2.99%68.11%Tata Chemicals
Revenue per Share (TTM)$908$582Samrat Pharmachem
Earnings per Share (Diluted)$15.59$12.49Samrat Pharmachem
Beta (Stock Volatility)-0.400.44Samrat Pharmachem
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Samrat Pharmachem vs Tata Chemicals Stock Performance Analysis

Loading Price Chart...

Samrat Pharmachem
Tata Chemicals
Samrat Pharmachem Stock Overview | Tata Chemicals Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Samrat Pharmachem-1.52%3.37%-4.23%-18.68%-2.82%-21.57%
Tata Chemicals0.14%0.15%-1.75%-0.26%15.77%-10.75%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Samrat Pharmachem-44.72%-69.64%176.70%598.52%1,337.94%1,818.75%
Tata Chemicals-21.67%-18.97%189.93%404.30%387.25%1,018.72%

News Based Sentiment: Samrat Pharmachem vs Tata Chemicals

Samrat Pharmachem

News based Sentiment: MIXED

October was a month of contrasting fortunes for Samrat Pharmachem, with a significant initial stock surge quickly followed by a decline to a 52-week low. This volatility, combined with mixed financial results, creates a complex investment picture that requires careful consideration.

View Samrat Pharmachem News Sentiment Analysis

Tata Chemicals

News based Sentiment: MIXED

October presented a mixed bag for Tata Chemicals with fluctuating financials, leadership changes, and the broader Tata Group's significant investment in semiconductors. While the company faces short-term revenue challenges, positive analyst sentiment and a favorable trade agreement offer potential for future growth, making it a cautiously optimistic investment.

View Tata Chemicals News Sentiment Analysis

Performance & Financial Health Analysis: Samrat Pharmachem vs Tata Chemicals

MetricSAMRATPHTATACHEM
Market Information
Market Cap i₹1.03B₹236.62B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,850768,531
90 Day Avg. Volume i1,306602,404
Last Close₹307.00₹926.75
52 Week Range₹289.00 - ₹425.00₹756.00 - ₹1,247.35
% from 52W High-27.76%-25.70%
All-Time High₹1,250.00 (Sep 19, 2022)₹1,349.00 (Mar 04, 2024)
% from All-Time High-75.44%-31.30%
Growth Metrics
Quarterly Revenue Growth-0.06%-0.02%
Quarterly Earnings Growth-0.06%0.68%
Financial Health
Profit Margin (TTM) i0.02%0.02%
Operating Margin (TTM) i0.00%0.10%
Return on Equity (TTM) i0.10%0.02%
Debt to Equity (MRQ) i13.8131.43
Cash & Liquidity
Book Value per Share (MRQ)₹232.02₹847.63
Cash per Share (MRQ)₹1.70₹54.98
Operating Cash Flow (TTM) i₹1.26M₹11.31B
Levered Free Cash Flow (TTM) i₹71.12M₹2.35B
Dividends
Last 12-Month Dividend Yield i0.29%1.19%
Last 12-Month Dividend i₹1.00₹11.00

Valuation & Enterprise Metrics Analysis: Samrat Pharmachem vs Tata Chemicals

MetricSAMRATPHTATACHEM
Price Ratios
P/E Ratio (TTM) i20.0075.13
Forward P/E iN/A19.02
PEG Ratio i-0.181.11
Price to Sales (TTM) i0.341.61
Price to Book (MRQ) i1.341.11
Market Capitalization
Market Capitalization i₹1.03B₹236.62B
Enterprise Value i₹1.06B₹301.60B
Enterprise Value Metrics
Enterprise to Revenue i0.382.04
Enterprise to EBITDA i13.6115.56
Risk & Other Metrics
Beta i-0.400.44
Book Value per Share (MRQ) i₹232.02₹847.63

Financial Statements Comparison: Samrat Pharmachem vs Tata Chemicals

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SAMRATPHTATACHEM
Revenue/Sales i₹756.52M₹37.19B
Cost of Goods Sold i₹733.90M₹11.86B
Gross Profit i₹22.62M₹25.33B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-456,000₹3.69B
EBITDA i₹8.16M₹7.87B
Pre-Tax Income i₹2.08M₹3.60B
Income Tax i₹4.37M₹440.00M
Net Income (Profit) i₹-2.29M₹3.16B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SAMRATPHTATACHEM
Cash & Equivalents i₹483,000₹5.48B
Total Current Assets i₹1.03B₹67.20B
Total Current Liabilities i₹495.83M₹61.39B
Long-Term Debt i₹0₹48.16B
Total Shareholders Equity i₹718.00M₹225.01B
Retained Earnings i₹687.11M₹92.79B
Property, Plant & Equipment i₹0₹4.31B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SAMRATPHTATACHEM
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSAMRATPHTATACHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,850768,531
Average Daily Volume (90 Day) i1,306602,404
Shares Outstanding i3.09M254.76M
Float Shares i1.26M156.06M
% Held by Insiders i0.59%0.39%
% Held by Institutions i0.00%0.30%

Dividend Analysis & Yield Comparison: Samrat Pharmachem vs Tata Chemicals

MetricSAMRATPHTATACHEM
Last 12-Month Dividend i₹1.00₹11.00
Last 12-Month Dividend Yield i0.29%1.19%
3-Year Avg Annual Dividend i₹1.67₹14.50
3-Year Avg Dividend Yield i0.17%1.45%
3-Year Total Dividends i₹5.00₹43.50
Ex-Dividend DateSep 19, 2024Jun 12, 2025